Abbott CardioMEMS Patient Therapy Access Patient Appeals Program

New Office Enrollment Form

 

Provider Enrollment - CardioMEMS

Portal User Information

User Contact Name
User Contact Name
First
Last

Practice Information

Practice Address
Practice Address
City
State
ZIP Code

Implanting Physician Information

Facility Information

Facility Address
Facility Address
City
State
ZIP Code

Onboarding Call Availability

Please select your timezone:
Time PST (Option 1)
Time PST (Option 2)
Time MST (Option 1)
Time MST (Option 2)
Time CST (Option 1)
Time CST (Option 2)
Time EST (Option 1)
Time EST (Option 2)

PROGRAM SUPPORT:

MONDAY–FRIDAY 8:30AM–5:00PM EST
PHONE: 860-733-0955  FAX: 860-801-8956
EMAIL: cardiomems@priahealthcare.com


IMPORTANT SAFETY INFORMATION
Rx Only
Brief Summary: Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions, potential adverse events and directions for use.
CardioMEMS™ HF System Indications and Usage: The CardioMEMS HF System is indicated for wirelessly measuring and monitoring pulmonary artery pressure and heart rate in NYHA Class II or III heart failure patients who either have been hospitalized for heart failure in the previous year and/or have elevated natriuretic peptides. The hemodynamic data are used by physicians for heart failure management with the goal of controlling pulmonary artery pressures and reducing heart failure hospitalizations.
CardioMEMS™ HF System Contraindications: The CardioMEMS™HF System is contraindicated for patients with an inability to take dual antiplatelet or anticoagulants for one month post implant.
CardioMEMS™ HF System Potential Adverse Events: Potential adverse events associated with the implantation procedure include, but are not limited to, the following: air embolism, allergic reaction, infection, delayed wound healing, arrhythmias, bleeding, hemoptysis, hematoma, nausea, cerebrovascular accident, thrombus, cardiovascular injury, myocardial infarction, death, embolization, thermal burn, cardiac perforation, pneumothorax, thoracic duct injury and hemothorax.
Disclaimer:
This material and the information contained herein is for general information purposes only and is not intended, and does not constitute, legal, reimbursement, business, clinical, or other advice. Furthermore, it is not intended to and does not constitute a representation or guarantee of reimbursement, payment, or charge, or that reimbursement or other payment will be received. It is not intended to increase or maximize payment by any payer. Abbott makes no express or implied warranty or guarantee that the list of codes and narratives in this document is complete or error-free. Similarly, nothing in this document should be viewed as instructions for selecting any particular code, and Abbott does not advocate or warrant the appropriateness of the use of any particular code. The ultimate responsibility for coding and obtaining payment/reimbursement remains with the customer. This includes the responsibility for accuracy and veracity of all coding and claims submitted to third-party payers. In addition, the customer should note that laws, regulations, and coverage policies are complex and are updated frequently and is subject to change without notice. The customer should check with its local carriers or intermediaries often and should consult with legal counsel or a financial, coding, or reimbursement specialist for any questions related to coding, billing, reimbursement, or any related issues. This material reproduces information for reference purposes only. It is not provided or authorized for marketing use.
Information contained herein for DISTRIBUTION in the U.S. ONLY.
Abbott
6101 Stoneridge Drive, Pleasanton, CA 94588 USA Tel: 1.925.847.8600
™ Indicates a trademark of the Abbott group of companies
© 2024 Abbott.  All rights reserved. MAT-2407496 v1.0 | Item approved for the U.S. use only.